Feasibility of a prospective host cell reactivation assay (HCRA) in non-small cell lung cancer (NSCLC) patients. Background: Procoagulant changes in the haemostatic system and activation of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. More than one-quarter of patients with COVID-19 had ...

Molecular analysis of RAS genes mutations in patients with cervical adenocarcinoma. The acceleration of adoption of tumor profiling into routine clinical practice: An insight from review of the ...

A screening blood test originally validated in seriously ill patients without COVID-19 is still clinically useful for ruling out pulmonary embolism in patients hospitalized with the coronavirus, a ...

A D-dimer test measures how much D-dimer protein is in the blood. This protein is present when blood clots break down. A typical range is 0 to 0.50 micrograms per milliliter (μg/mL) of blood. Higher ...

A D-dimer test measures a protein fragment that remains in the blood after blood clots break down. It can help diagnose clotting conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), ...

Although D-dimer results within a typical range can rule out pulmonary embolism, high results alone can’t diagnose this condition. Doctors usually need to run extra tests to make a diagnosis. A ...

D dimer is a blood test that evaluates levels of a protein fragment when there's a clot hanging around in the bloodstream. If this level is elevated, it's often a tip-off that there was a tiny blood ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The plasma D-dimer assay has been used, along with clinical prediction scores, to rule out ...

Tampa, FL (Oct. 26, 2021) --A screening blood test originally validated in seriously ill patients without COVID-19 is still clinically useful for ruling out pulmonary embolism in patients hospitalized ...